|
0
|
|
Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study.
(journals.asm.org)
|
Patel M
…
Gheyas F
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#amr
#pneumonia
|
|
0
|
|
Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human study.
(journals.asm.org)
|
Darpo B
…
Xue H
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#clinical trial
#cardiotoxicity
#tb
|
|
0
|
|
Safety concerns associated with high-dose continuous infusion of cefepime among critically ill patients with mild renal impairment to augmented renal clearance at a level 1 trauma center: CEFTOX study.
(journals.asm.org)
|
Lamamri M
…
Jeantrelle C
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#neurotoxicity
#sepsis
#therapeutic drug monitoring
#renal clearance
|
|
0
|
|
Beyond plasma: defining the translation value of epithelial lining fluid exposure profiles for the treatment of pneumonia.
(academic.oup.com)
|
Fu Y
…
Nicolau DP
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#pneumonia
#pharmacodynamics
#antibiotic
|
|
0
|
|
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit.
(academic.oup.com)
|
Hendrickx S
…
Caljon G
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#drug discovery
#parasitic infection
#kinetoplastid
#preclinical
|
|
0
|
|
Identification and assessment of paediatric cefepime-induced neurotoxicity in a retrospective cohort of paediatric intensive care patients.
(academic.oup.com)
|
Pavia K
…
Tang Girdwood S
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#neurotoxicity
#antibiotic
#pediatric
#adverse drug reaction
|
|
0
|
|
Antimicrobial therapy for infected necrotizing pancreatitis: microbiology, antimicrobial resistance and pharmacokinetics.
(academic.oup.com)
|
Pauw HS
…
van Den Berg FF
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#amr
#microbiology
|
|
0
|
|
Population pharmacokinetics of meropenem in critically ill adult patients receiving extracorporeal membrane oxygenation-an ASAP ECMO study.
(academic.oup.com)
|
Abdul-Aziz MH
…
Roberts JA
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#dosing
#sepsis
#ecmo
|
|
0
|
|
Continuous linezolid infusion: the new way to dose, the old risks to fear.
(academic.oup.com)
|
Munoz-Pichuante D
…
Villa-Zapata L
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#dosing
#amr
#toxicity
#therapeutic drug monitoring
|
|
0
|
|
Extrapolation of oritavancin PK/PD targets to inform therapeutic drug monitoring: a systematic review.
(academic.oup.com)
|
Baiardi G
…
Mattioli F
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#amr
#pharmacodynamics
#therapeutic drug monitoring
#bactericidal
|
|
0
|
|
Population pharmacokinetic model and dosing nomogram for daptomycin in adult patients with serious Gram-positive infections: emphasizing the role of loading doses and renal function-based adjustment.
(journals.asm.org)
|
Subrtova P
…
Sima M
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#dosing
#infection
#amr
|
|
0
|
|
Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
(journals.asm.org)
|
Lepak A
…
Andes D
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#infection
#amr
#aspergillosis
|
|
0
|
|
Pharmacokinetic and pharmacodynamic modeling of anti-plasmodial drugs mefloquine plus artesunate: insights on translational application.
(journals.asm.org)
|
Mim SR
…
Azeredo FJ
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#modeling
#dosing
#malaria
#pharmacodynamics
|
|
0
|
|
Variations in ventricular distribution of polymyxin B following intraventricular administration in patients with central nervous system infections.
(journals.asm.org)
|
Jiang H
…
Yan W
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#amr
#meningitis
|
|
0
|
|
Protein binding of vancomycin in a large mixed patient population at a university hospital.
(journals.asm.org)
|
Dejaco A
…
Kees MG
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#antibiotic
#therapeutic drug monitoring
#protein-binding
|
|
0
|
|
Optimization strategies for voriconazole dosing in pediatric populations: integrating therapeutic indications and age-stratified pharmacokinetics.
(journals.asm.org)
|
Zhu Y
…
Huang L
Antimicrobial Agents and Chemotherapy
2026-03-04
|
#pharmacokinetics
#dosing
#metabolism
#antifungal
#pediatric
|
|
0
|
|
Cefuroxime concentrations in facial artery musculomucosal flap, buccal submucosa, subcutaneous tissue, and plasma following bolus or continuous infusion in patients undergoing oral cancer resection: a randomized clinical microdialysis study.
(academic.oup.com)
|
Hansen JR
…
Klug TE
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#antibiotic
#surgery
#microdialysis
|
|
0
|
|
Impact of loading dose beta-lactam therapy on outcomes of KPC-producing Klebsiella pneumoniae bloodstream infections in non-ICU patients: a real world study.
(academic.oup.com)
|
Frallonardo L
…
Saracino A
Journal of Antimicrobial Chemotherapy
2026-03-04
|
#pharmacokinetics
#infection
#amr
#antibiotic
#bacteremia
|